Research theme for competitive and other funds (3):
2024 - 2027 Development of new gene panel system for molecular classification of endometrial cancer and genetic analysis to search for therapeutic targets
2022 - 2025 Comprehensive Search for Early Diagnostic Markers and Therapeutic Targets for Cervical Cancer Using Circular RNA in Blood
2016 - 2019 Elucidation of the miRNA-EZH2 feedback loop regulating endometrial cancer microenvironment
Papers (48):
Yosuke Konno, Shunsuke Ohnishi, Shinichiro Minobe, Eiji Nomura, Takayuki Nagasawa, Etsuko Fujimoto, Tatsuru Ohara, Shin Nishio, Hisamori Kato, Yoshihito Yokoyama, et al. Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients With Uterine Corpus or Cervical Cancer Treated With Cisplatin-Based Regimen-Placebo-controlled, Double-Blind, Randomized Confirmatory Study (JORTC-KMP03). Integrative Cancer Therapies. 2025
Yosuke Konno, Michinori Mayama, Kazuhiro Takehara, Yoshihito Yokoyama, Jiro Suzuki, Nobuyuki Susumu, Kenichi Harano, Satoshi Nakagawa, Toru Nakanishi, Wataru Yamagami, et al. Prognostic significance of para-aortic node metastasis in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis. Journal of Gynecologic Oncology. 2025
Yosuke Konno, Michinori Mayama, Kazuhiro Takehara, Yoshihito Yokoyama, Jiro Suzuki, Nobuyuki Susumu, Kenichi Harano, Satoshi Nakagawa, Toru Nakanishi, Wataru Yamagami, et al. Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis. Journal of gynecologic oncology. 2024
Shogo Shigeta, Yosuke Konno, Yoshito Terai, Tohru Morisada, Hideki Tokunaga, Tsukasa Baba, Yoichi Kobayashi, Satoru Nagase. A qualitative systematic review of the significance of adjuvant therapy in patients with low-risk endometrial cancer presenting positive peritoneal cytology: a relevant study to the guideline update for endometrial cancer by the Japan society of gynecologic oncology guideline committee. Japanese journal of clinical oncology. 2023